Perspectives on Diversion of Medications From Safer Opioid Supply Programs
Diversion encompasses a wide spectrum of practices (selling, sharing, and loss of medications), and occurs for complex reasons that surveillance and punitive measures are unlikely to mitigate. Diversion may be best addressed by expanding medication options to better match patients' diverse substance use needs and high tolerance, alongside wraparound social supports.
Authors
- Rose A. Schmidt (ORCID: https://orcid.org/0000-0002-0307-8482)
- Katherine Rudzinski (ORCID: https://orcid.org/0000-0001-8501-9891)
- Carol Strıke (ORCID: https://orcid.org/0000-0002-2716-3681)
- Danielle German (ORCID: https://orcid.org/0000-0001-9604-5817)
- Gillian Kolla (ORCID: https://orcid.org/0000-0002-5743-7153)
- Adrian Guţă (ORCID: https://orcid.org/0000-0002-1380-2016)
- Andrea Sereda
- Michelle Olding
Institutions
- Memorial University of Newfoundland (CA)
- Johns Hopkins University (US)
- University of Toronto (CA)
- London Health Sciences Centre (CA)
- Public Health Ontario (CA)
- University of Windsor (CA)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.51988
- Citations
- 11
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.97
Funders
- Canadian Institutes of Health Research